2022 Q1 Form 10-Q Financial Statement
#000156459022019879 Filed on May 12, 2022
Income Statement
Concept | 2022 Q1 | 2021 Q4 | 2021 Q1 |
---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 |
YoY Change | -100.0% | -100.0% | |
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $5.957M | $6.504M | $8.430M |
YoY Change | -29.34% | -9.29% | -3.44% |
% of Gross Profit | |||
Research & Development | $17.21M | $14.75M | $18.55M |
YoY Change | -7.27% | -55.99% | -19.51% |
% of Gross Profit | |||
Depreciation & Amortization | $120.0K | $120.0K | $107.0K |
YoY Change | 12.15% | -61.29% | -6.96% |
% of Gross Profit | |||
Operating Expenses | $23.16M | $21.25M | $27.26M |
YoY Change | -15.03% | -47.76% | -14.22% |
Operating Profit | -$23.16M | -$27.26M | |
YoY Change | -15.03% | -1.57% | |
Interest Expense | $71.00K | $101.0K | $60.00K |
YoY Change | 18.33% | -54.09% | -94.23% |
% of Operating Profit | |||
Other Income/Expense, Net | $71.00K | $58.00K | |
YoY Change | 22.41% | -94.42% | |
Pretax Income | -$23.09M | -$62.79M | -$27.20M |
YoY Change | -15.11% | 59.28% | 2.04% |
Income Tax | -$2.531M | ||
% Of Pretax Income | |||
Net Earnings | -$23.09M | -$60.26M | -$27.20M |
YoY Change | -15.11% | 52.87% | 2.04% |
Net Earnings / Revenue | |||
Basic Earnings Per Share | -$0.48 | ||
Diluted Earnings Per Share | -$479.8K | -$1.341M | -$685.5K |
COMMON SHARES | |||
Basic Shares Outstanding | 48.12M | ||
Diluted Shares Outstanding | 48.12M |
Balance Sheet
Concept | 2022 Q1 | 2021 Q4 | 2021 Q1 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $123.0M | $146.6M | $214.9M |
YoY Change | -42.76% | -32.25% | -13.74% |
Cash & Equivalents | $51.17M | $45.63M | $78.25M |
Short-Term Investments | $71.83M | $101.0M | $136.6M |
Other Short-Term Assets | $7.253M | $7.241M | $6.500M |
YoY Change | 11.58% | 4.94% | 41.3% |
Inventory | |||
Prepaid Expenses | |||
Receivables | $524.0K | $336.0K | $200.0K |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $130.8M | $154.2M | $221.6M |
YoY Change | -40.99% | -31.31% | -13.69% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $6.319M | $1.139M | $9.600M |
YoY Change | -34.18% | -28.81% | 439.33% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | $23.46M | $27.97M | |
YoY Change | |||
Other Assets | $2.175M | $1.703M | $6.000M |
YoY Change | -63.75% | -73.36% | 261.23% |
Total Long-Term Assets | $31.95M | $36.86M | $57.30M |
YoY Change | -44.24% | -37.28% | 1.31% |
TOTAL ASSETS | |||
Total Short-Term Assets | $130.8M | $154.2M | $221.6M |
Total Long-Term Assets | $31.95M | $36.86M | $57.30M |
Total Assets | $162.7M | $191.1M | $278.9M |
YoY Change | -41.65% | -32.55% | -10.98% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $1.407M | $2.659M | $3.600M |
YoY Change | -60.92% | -42.17% | 71.1% |
Accrued Expenses | $2.499M | $6.863M | $3.659M |
YoY Change | -31.7% | -42.75% | -17.4% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $10.71M | $16.07M | $14.50M |
YoY Change | -26.14% | -34.22% | -31.43% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | $5.230M | $6.058M | $14.60M |
YoY Change | -64.18% | -61.41% | -61.48% |
Total Long-Term Liabilities | $5.230M | $6.058M | $14.60M |
YoY Change | -64.18% | -61.41% | -61.48% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $10.71M | $16.07M | $14.50M |
Total Long-Term Liabilities | $5.230M | $6.058M | $14.60M |
Total Liabilities | $15.94M | $22.13M | $31.70M |
YoY Change | -49.72% | -48.14% | -48.49% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$654.5M | -$631.4M | |
YoY Change | 25.89% | ||
Common Stock | $802.2M | $800.8M | |
YoY Change | 7.86% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $146.8M | $168.9M | $247.2M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $162.7M | $191.1M | $278.9M |
YoY Change | -41.65% | -32.55% | -10.98% |
Cashflow Statement
Concept | 2022 Q1 | 2021 Q4 | 2021 Q1 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$23.09M | -$60.26M | -$27.20M |
YoY Change | -15.11% | 52.87% | 2.04% |
Depreciation, Depletion And Amortization | $120.0K | $120.0K | $107.0K |
YoY Change | 12.15% | -61.29% | -6.96% |
Cash From Operating Activities | -$27.50M | -$19.36M | -$33.34M |
YoY Change | -17.52% | -23.38% | 32.22% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $0.00 | -$18.00K | $3.078M |
YoY Change | -100.0% | -98.97% | 4635.38% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $33.05M | -$8.466M | $21.09M |
YoY Change | 56.7% | -137.69% | 1.59% |
Cash From Investing Activities | $33.05M | -$8.484M | $18.02M |
YoY Change | 83.44% | -140.97% | -12.94% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | $34.14M | ||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 0.000 | 2.713M | 34.14M |
YoY Change | -100.0% | -52.32% | 28586.55% |
NET CHANGE | |||
Cash From Operating Activities | -27.50M | -19.36M | -33.34M |
Cash From Investing Activities | 33.05M | -8.484M | 18.02M |
Cash From Financing Activities | 0.000 | 2.713M | 34.14M |
Net Change In Cash | -27.50M | -25.13M | 18.81M |
YoY Change | -246.22% | -2324.16% | -526.9% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$27.50M | -$19.36M | -$33.34M |
Capital Expenditures | $0.00 | -$18.00K | $3.078M |
Free Cash Flow | -$27.50M | -$19.34M | -$36.42M |
YoY Change | -24.49% | -17.76% | 44.06% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2022Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2021Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2022Q1 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
CY2021Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
CY2022Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | |
CY2021Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | |
CY2022Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2021Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2022Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2021Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2021Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
6863000 | |
CY2022Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
3207000 | |
CY2021Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
3151000 | |
CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | |
CY2022Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
10709000 | |
CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | |
CY2022Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
48132937 | |
CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
48132937 | |
CY2022Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
48120437 | |
CY2021Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
16073000 | |
CY2022Q1 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
2733000 | |
CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
48120437 | |
CY2022Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
48000 | |
CY2021Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
48000 | |
CY2022Q1 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
802170000 | |
CY2021Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
800728000 | |
CY2022Q1 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-908000 | |
CY2021Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-419000 | |
CY2022Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-654519000 | |
CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-631428000 | |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
146791000 | |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
168929000 | |
CY2021Q4 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
2733000 | |
CY2022Q1 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
2497000 | |
CY2021Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
3325000 | |
CY2022Q1 | us-gaap |
Liabilities
Liabilities
|
15939000 | |
CY2021Q4 | us-gaap |
Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
|
27972000 | |
CY2022Q1 | us-gaap |
Assets
Assets
|
162730000 | |
CY2021Q4 | us-gaap |
Assets
Assets
|
191060000 | |
CY2022Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1407000 | |
CY2021Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
2659000 | |
CY2022Q1 | asmb |
Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
|
3596000 | |
CY2021Q4 | asmb |
Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
|
3400000 | |
CY2022Q1 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
2499000 | |
CY2021Q4 | us-gaap |
Liabilities
Liabilities
|
22131000 | |
CY2022Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2021Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
162730000 | |
CY2021Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
191060000 | |
CY2022Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.48 | |
CY2021Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.69 | |
CY2022Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
17205000 | |
CY2021Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
18554000 | |
CY2022Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
5957000 | |
CY2021Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
8704000 | |
CY2022Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
23162000 | |
CY2021Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
27258000 | |
CY2022Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-23162000 | |
CY2021Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-27258000 | |
CY2022Q1 | us-gaap |
Interest Income Other
InterestIncomeOther
|
71000 | |
CY2021Q1 | us-gaap |
Interest Income Other
InterestIncomeOther
|
58000 | |
CY2022Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
71000 | |
CY2021Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
58000 | |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-23091000 | |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-27200000 | |
CY2022Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-489000 | |
CY2021Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-1000 | |
CY2022Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-23580000 | |
CY2021Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-27201000 | |
CY2022Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
48123930 | |
CY2021Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
39679734 | |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
168929000 | |
CY2022Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-489000 | |
CY2022Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1442000 | |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
146791000 | |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
240578000 | |
CY2021Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
34137000 | |
CY2021Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-1000 | |
CY2021Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
-270000 | |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-27200000 | |
CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
247244000 | |
CY2022Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-23091000 | |
CY2021Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-27200000 | |
CY2022Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
120000 | |
CY2022Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1443000 | |
CY2022Q1 | asmb |
Amortization Of Investments In Marketable Debt Securities
AmortizationOfInvestmentsInMarketableDebtSecurities
|
-149000 | |
CY2021Q1 | asmb |
Amortization Of Investments In Marketable Debt Securities
AmortizationOfInvestmentsInMarketableDebtSecurities
|
-92000 | |
CY2022Q1 | asmb |
Noncash Rent Expense
NoncashRentExpense
|
893000 | |
CY2022Q1 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
0 | |
CY2021Q1 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-1611000 | |
CY2021Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-1027000 | |
CY2021Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-303000 | |
CY2021Q1 | us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
-358000 | |
CY2021Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-1036000 | |
CY2022Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
0 | |
CY2022Q1 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
0 | |
CY2022Q1 | asmb |
Increase Decrease In Accrued Research And Development Expenses
IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses
|
196000 | |
CY2021Q1 | asmb |
Increase Decrease In Accrued Research And Development Expenses
IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses
|
-102000 | |
CY2021Q1 | us-gaap |
Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
|
-8312000 | |
CY2022Q1 | asmb |
Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
|
-923000 | |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-27502000 | |
CY2021Q1 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
857000 | |
CY2021Q1 | us-gaap |
Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
49213000 | |
CY2021Q1 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
66450000 | |
CY2021Q1 | us-gaap |
Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
|
3000000 | |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
18016000 | |
CY2022Q1 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | |
CY2022Q1 | asmb |
Number Of Approved Products
NumberOfApprovedProducts
|
0 | |
CY2022Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that may affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Estimates inherent in the preparation of the accompanying unaudited condensed consolidated financial statements include estimates of costs incurred but not yet invoiced for research and development accruals, recoverability and useful lives of our long-lived assets, amounts receivable under collaboration agreements, measurement of operating lease liabilities, and the fair value of stock options, stock appreciation rights, and RSUs granted to employees, directors, and consultants.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:10pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible these external factors could have an effect on the Company’s estimates and could cause actual results to differ materially from those estimates and assumptions.</p> | |
CY2022Q1 | asmb |
Capitalized And Amortized Costs Period
CapitalizedAndAmortizedCostsPeriod
|
P5Y | |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-23091000 | |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-27200000 | |
CY2022Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
48123930 | |
CY2021Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
39679734 | |
CY2022Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.48 | |
CY2021Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.69 | |
CY2022Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
9158738 | |
CY2021Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
8093959 | |
CY2022Q1 | asmb |
Cash Equivalents At Carrying Value And Available For Sale Debt Securities Amortized Cost
CashEquivalentsAtCarryingValueAndAvailableForSaleDebtSecuritiesAmortizedCost
|
144281000 | |
CY2022Q1 | asmb |
Cash Equivalents At Carrying Value And Available For Sale Debt Securities Gross Unrealized Gain
CashEquivalentsAtCarryingValueAndAvailableForSaleDebtSecuritiesGrossUnrealizedGain
|
0 | |
CY2022Q1 | asmb |
Cash Equivalents At Carrying Value And Available For Sale Debt Securities Gross Unrealized Loss
CashEquivalentsAtCarryingValueAndAvailableForSaleDebtSecuritiesGrossUnrealizedLoss
|
635000 | |
CY2022Q1 | asmb |
Cash Equivalents At Carrying Value And Available For Sale Debt Securities Estimated Fair Value
CashEquivalentsAtCarryingValueAndAvailableForSaleDebtSecuritiesEstimatedFairValue
|
143646000 | |
CY2021Q4 | asmb |
Cash Equivalents At Carrying Value And Available For Sale Debt Securities Amortized Cost
CashEquivalentsAtCarryingValueAndAvailableForSaleDebtSecuritiesAmortizedCost
|
171625000 | |
CY2021Q4 | asmb |
Cash Equivalents At Carrying Value And Available For Sale Debt Securities Gross Unrealized Gain
CashEquivalentsAtCarryingValueAndAvailableForSaleDebtSecuritiesGrossUnrealizedGain
|
0 | |
CY2021Q4 | asmb |
Cash Equivalents At Carrying Value And Available For Sale Debt Securities Gross Unrealized Loss
CashEquivalentsAtCarryingValueAndAvailableForSaleDebtSecuritiesGrossUnrealizedLoss
|
146000 | |
CY2021Q4 | asmb |
Cash Equivalents At Carrying Value And Available For Sale Debt Securities Estimated Fair Value
CashEquivalentsAtCarryingValueAndAvailableForSaleDebtSecuritiesEstimatedFairValue
|
171479000 | |
CY2021Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
437000 | |
CY2022Q1 | asmb |
Fair Value Assets Between Levels Transfers Amount
FairValueAssetsBetweenLevelsTransfersAmount
|
0 | |
CY2021Q4 | asmb |
Fair Value Assets Between Levels Transfers Amount
FairValueAssetsBetweenLevelsTransfersAmount
|
0 | |
CY2022Q1 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
2161000 | |
CY2021Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
6426000 | |
CY2022Q1 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
338000 | |
CY2022Q1 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
2499000 | |
CY2021Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
6863000 | |
CY2020Q3 | asmb |
Initial Public Offering Value Of Shares Authorized
InitialPublicOfferingValueOfSharesAuthorized
|
300000000.0 | |
CY2020Q3 | asmb |
Initial Public Offering Value Of Shares Authorized
InitialPublicOfferingValueOfSharesAuthorized
|
300000000.0 | |
CY2021Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
|
6600000 | |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
1.63 | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
3.15 | |
CY2022Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
0 | |
CY2021Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
0 | |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | |
CY2022Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1443000 | |
CY2021Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
-286000 | |
CY2022Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
|
10900000 | |
CY2022Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P1Y9M18D | |
CY2022Q1 | us-gaap |
Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
|
800000 | |
CY2022Q1 | asmb |
Milestone Payment Diligence Maintenance Fees
MilestonePaymentDiligenceMaintenanceFees
|
100000 | |
CY2021Q1 | asmb |
Milestone Payment Diligence Maintenance Fees
MilestonePaymentDiligenceMaintenanceFees
|
0 |